Imaging in hypertensive heart disease

References

• Janardhanan R, Desai AS, Solomon SD. Therapeutic approaches to diastolic dysfunction. Curr. Hypertens. Rep.11(4), 283–291 (2009).
   PubMed Web of Science ®Google Scholar
• Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA275(20), 1557–1562 (1996).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann. Intern. Med.72(6), 813–822 (1970).
   PubMedGoogle Scholar
• Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med.322(22), 1561–1566 (1990).
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am. J. Cardiol.78(2), 197–202 (1996).
   PubMed Web of Science ®Google Scholar
• Wachtell K, Bella JN, Rokkedal J et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation105(9), 1071–1076 (2002).
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Jern S et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA292(19), 2343–2349 (2004).
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Borgioni C et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation97(1), 48–54 (1998).
   PubMed Web of Science ®Google Scholar
• McLenachan JM, Henderson E, Morris KI, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N. Engl. J. Med.317(13), 787–792 (1987).
   PubMed Web of Science ®Google Scholar
• Dimopoulos S, Nicosia F, Donati P et al. QT dispersion and left ventricular hypertrophy in elderly hypertensive and normotensive patients. Angiology59(5), 605–612 (2008).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol.82(8A), 2N–9N (1998).
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA292(19), 2350–2356 (2004).
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol.57(6), 450–458 (1986).
   PubMed Web of Science ®Google Scholar
• Savage DD, Garrison RJ, Kannel WB et al. The spectrum of left-ventricular hypertrophy in a general-population sample – the Framingham-Study. Circulation75(1), 26–33 (1987).
   PubMed Web of Science ®Google Scholar
• Li L, Shigematsu Y, Hamada M, Hiwada K. Relative wall thickness is an independent predictor of left ventricular systolic and diastolic dysfunctions in essential hypertension. Hypertens. Res.24(5), 493–499 (2001).
   PubMed Web of Science ®Google Scholar
• Palmieri V, Wachtell K, Bella JN et al. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. J. Hum. Hypertens.18(6), 423–430 (2004).
   PubMed Web of Science ®Google Scholar
• Ganau A, Devereux RB, Roman MJ et al. Patterns of left-ventricular hypertrophy and geometric remodeling in essential-hypertension. J. Am. Coll. Cardiol.19(7), 1550–1558 (1992).
   PubMed Web of Science ®Google Scholar
• Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc. Ultrasound3, 17 (2005).
   PubMedGoogle Scholar
• Verdecchia P, Schillaci G, Borgioni C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J. Am. Coll. Cardiol.25(4), 871–878 (1995).
   PubMed Web of Science ®Google Scholar
• Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med.114(5), 345–352 (1991).
   PubMed Web of Science ®Google Scholar
• Savage DD, Drayer JI, Henry WL et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation59(4), 623–632 (1979).
   PubMed Web of Science ®Google Scholar
• Devereux RB, Savage DD, Drayer JI, Laragh JH. Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension4(4), 524–531 (1982).
   PubMed Web of Science ®Google Scholar
• Salcedo EE, Gockowski K, Tarazi RC. Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models. Am. J. Cardiol.44(5), 936–940 (1979).
   PubMed Web of Science ®Google Scholar
• Korner PI, Jennings GL. Assessment of prevalence of left ventricular hypertrophy in hypertension. J. Hypertens.16(6), 715–723 (1998).
   PubMed Web of Science ®Google Scholar
• Alfakih K, Reid S, Hall A, Sivananthan MU. The assessment of left ventricular hypertrophy in hypertension. J. Hypertens.24(7), 1223–1230 (2006).
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Muiesan ML, Salvetti M. Evaluation of subclinical target organ damage for risk assessment and treatment in the hypertensive patients: left ventricular hypertrophy. J. Am. Soc. Nephrol.17(4 Suppl. 2), S104–S108 (2006).
   Web of Science ®Google Scholar
• Buck T, Hunold P, Wentz KU, Tkalec W, Nesser HJ, Erbel R. Tomographic three-dimensional echocardiographic determination of chamber size and systolic function in patients with left ventricular aneurysm: comparison to magnetic resonance imaging, cineventriculography, and two-dimensional echocardiography. Circulation96(12), 4286–4297 (1997).
   PubMed Web of Science ®Google Scholar
• Gutberlet M, Abdul-Khaliq H, Grothoff M et al. [Evaluation of left ventricular volumes in patients with congenital heart disease and abnormal left ventricular geometry. Comparison of MRI and transthoracic 3-dimensional echocardiography]. Rofo175(7), 942–951 (2003).
   PubMedGoogle Scholar
• Kuhl HP, Schreckenberg M, Rulands D et al. High-resolution transthoracic real-time three-dimensional echocardiography: quantitation of cardiac volumes and function using semi-automatic border detection and comparison with cardiac magnetic resonance imaging. J. Am. Coll. Cardiol.43(11), 2083–2090 (2004).
   PubMed Web of Science ®Google Scholar
• von Bardeleben RS, Kuhl HP, Mohr-Kahaly S, Franke A. Second-generation real-time three-dimensional echocardiography. Finally on its way into clinical cardiology? Z. Kardiol.93(Suppl. 4), IV56–IV64 (2004).
   Google Scholar
• Missouris CG, Forbat SM, Singer DR, Markandu ND, Underwood R, MacGregor GA. Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J. Hypertens.14(8), 1005–1010 (1996).
   PubMed Web of Science ®Google Scholar
• Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension40(5), 673–678 (2002).
   PubMed Web of Science ®Google Scholar
• Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS. Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am. J. Hypertens.8(3), 221–228 (1995).
   PubMed Web of Science ®Google Scholar
• Papavassiliu T, Kuhl HP, van Dockum W et al. Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging. J. Cardiovasc. Magn. Reson.6(4), 845–854 (2004).
   PubMed Web of Science ®Google Scholar
• Sakuma H, Fujita N, Foo TK et al. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology188(2), 377–380 (1993).
   PubMed Web of Science ®Google Scholar
• Pattynama PM, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology187(1), 261–268 (1993).
   PubMed Web of Science ®Google Scholar
• Katz J, Milliken MC, Stray-Gundersen J et al. Estimation of human myocardial mass with MR imaging. Radiology169(2), 495–498 (1988).
   PubMed Web of Science ®Google Scholar
• Florentine MS, Grosskreutz CL, Chang W et al. Measurement of left ventricular mass in vivo using gated nuclear magnetic resonance imaging. J. Am. Coll. Cardiol.8(1), 107–112 (1986).
   PubMed Web of Science ®Google Scholar
• Keller AM, Peshock RM, Malloy CR et al.In vivo measurement of myocardial mass using nuclear magnetic resonance imaging. J. Am. Coll. Cardiol.8(1), 113–117 (1986).
   PubMed Web of Science ®Google Scholar
• Devereux RB, Dahlof B, Gerdts E et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation110(11), 1456–1462 (2004).
   PubMed Web of Science ®Google Scholar
• Grothues F, Smith GC, Moon JC et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am. J. Cardiol.90(1), 29–34 (2002).
   PubMed Web of Science ®Google Scholar
• Reichek N, Devereux RB, Rocha RA et al. Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension. Hypertension54(4), 731–737 (2009).
   PubMed Web of Science ®Google Scholar
• Pitt B, Reichek N, Willenbrock R et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation108(15), 1831–1838 (2003).
   PubMed Web of Science ®Google Scholar
• Shimizu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Left ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation83(5), 1676–1684 (1991).
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation93(2), 259–265 (1996).
   PubMed Web of Science ®Google Scholar
• Lew WY, LeWinter MM. Regional comparison of midwall segment and area shortening in the canine left ventricle. Circ. Res.58(5), 678–691 (1986).
   PubMed Web of Science ®Google Scholar
• Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology171(3), 841–845 (1989).
   PubMed Web of Science ®Google Scholar
• Young AA, Imai H, Chang CN, Axel L. Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. Circulation89(2), 740–752 (1994).
   PubMed Web of Science ®Google Scholar
• Clark NR, Reichek N, Bergey P et al. Circumferential myocardial shortening in the normal human left ventricle. Assessment by magnetic resonance imaging using spatial modulation of magnetization. Circulation84(1), 67–74 (1991).
   PubMed Web of Science ®Google Scholar
• Palmon LC, Reichek N, Yeon SB et al. Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation89(1), 122–131 (1994).
   PubMed Web of Science ®Google Scholar
• Osman NF, Prince JL. Visualizing myocardial function using HARP MRI. Physics Med. Biol.45(6), 1665–1682 (2000).
   PubMed Web of Science ®Google Scholar
• Rosen BD, Saad MF, Shea S et al. Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic: individuals the Multi-Ethnic Study of Atherosclerosis. J. Am. Coll. Cardiol.47(6), 1150–1158 (2006).
   PubMed Web of Science ®Google Scholar
• Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu. Rev. Med.55, 373–394 (2004).
   PubMed Web of Science ®Google Scholar
• Aurigemma GP, Gaasch WH. Diastolic heart failure. N. Engl. J. Med.351(11), 1097–1105 (2004).
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA289(2), 194–202 (2003).
   PubMed Web of Science ®Google Scholar
• Wachtell K, Smith G, Gerdts E et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint. Am. J. Cardiol.85(4), 466–472 (2000).
   PubMed Web of Science ®Google Scholar
• Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation105(11), 1387–1393 (2002).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Levy D, Cupples LA. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. J. Cardiovasc. Pharmacol.10(Suppl. 6), S135–S140 (1987).
   PubMedGoogle Scholar
• Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J. Am. Coll. Cardiol.8(6), 1449–1454 (1986).
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J. Am. Coll. Cardiol.30(1), 8–18 (1997).
   PubMed Web of Science ®Google Scholar
• Schillaci G, Pasqualini L, Verdecchia P et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J. Am. Coll. Cardiol.39(12), 2005–2011 (2002).
   PubMed Web of Science ®Google Scholar
• Ishida Y, Meisner JS, Tsujioka K et al. Left ventricular filling dynamics: influence of left ventricular relaxation and left atrial pressure. Circulation74(1), 187–196 (1986).
   PubMedGoogle Scholar
• Choong CY, Herrmann HC, Weyman AE, Fifer MA. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. J. Am. Coll. Cardiol.10(4), 800–808 (1987).
   PubMed Web of Science ®Google Scholar
• Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J. Am. Soc. Echocardiogr.14(12), 1143–1152 (2001).
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J. Am. Coll. Cardiol.30(6), 1527–1533 (1997).
   PubMed Web of Science ®Google Scholar
• Sohn DW, Chai IH, Lee DJ et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J. Am. Coll. Cardiol.30(2), 474–480 (1997).
   PubMed Web of Science ®Google Scholar
• Hurlburt HM, Aurigemma GP, Hill JC et al. Direct ultrasound measurement of longitudinal, circumferential, and radial strain using 2-dimensional strain imaging in normal adults. Echocardiography24(7), 723–731 (2007).
   PubMed Web of Science ®Google Scholar
• Amundsen BH, Helle-Valle T, Edvardsen T et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J. Am. Coll. Cardiol.47(4), 789–793 (2006).
   PubMed Web of Science ®Google Scholar
• Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ. Cardiovasc. Imaging2(5), 382–390 (2009).
   PubMed Web of Science ®Google Scholar
• Solomon SD, Janardhanan R, Verma A et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet369(9579), 2079–2087 (2007).
   PubMed Web of Science ®Google Scholar
• Rathi VK, Doyle M, Yamrozik J et al. Routine evaluation of left ventricular diastolic function by cardiovascular magnetic resonance: a practical approach. J. Cardiovasc. Magn. Reson.10, 36 (2008).
   PubMed Web of Science ®Google Scholar
• Rathi VK, Biederman RW. Expanding role of cardiovascular magnetic resonance in left and right ventricular diastolic function. Heart Fail. Clin.5(3), 421–435, vii (2009).
   PubMedGoogle Scholar
• Querejeta R, Varo N, Lopez B et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation101(14), 1729–1735 (2000).
   PubMed Web of Science ®Google Scholar
• Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation91(1), 161–170 (1995).
   PubMed Web of Science ®Google Scholar
• Kass DA, Bronzwaer JG, Paulus WJ. What mechanisms underlie diastolic dysfunction in heart failure? Circ. Res.94(12), 1533–1542 (2004).
   PubMed Web of Science ®Google Scholar
• Martos R, Baugh J, Ledwidge M et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation115(7), 888–895 (2007).
   PubMed Web of Science ®Google Scholar
• Mizuno R, Fujimoto S, Saito Y, Nakamura S. Non-invasive quantitation of myocardial fibrosis using combined tissue harmonic imaging and integrated backscatter analysis in dilated cardiomyopathy. Cardiology108(1), 11–17 (2007).
   PubMed Web of Science ®Google Scholar
• Raman SV. The hypertensive heart. An integrated understanding informed by imaging. J. Am. Coll. Cardiol.55(2), 91–96 (2010).
   PubMed Web of Science ®Google Scholar
• Rudolph A, Abdel-Aty H, Bohl S et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J. Am. Coll. Cardiol.53(3), 284–291 (2009).
   PubMed Web of Science ®Google Scholar
• Moreo A, Ambrosio G, De Chiara B et al. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Circ. Cardiovasc. Imaging2(6), 437–443 (2009).
   PubMed Web of Science ®Google Scholar
• Iles L, Pfluger H, Phrommintikul A et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J. Am. Coll. Cardiol.52(19), 1574–1580 (2008).
   PubMed Web of Science ®Google Scholar
• Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation102(12), 1388–1393 (2000).
   PubMed Web of Science ®Google Scholar
• Marcus ML, Koyanagi S, Harrison DG, Doty DB, Hiratzka LF, Eastham CL. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am. J. Med.75(3A), 62–66 (1983).
   PubMed Web of Science ®Google Scholar
• Poe ND, Eber LM, Norman AS, Selin CE, Terao EN. Myocardial images in nonacute coronary and noncoronary heart diseases. J. Nucl. Med.18(1), 18–23 (1977).
   PubMed Web of Science ®Google Scholar
• Picano E, Palinkas A, Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J. Hypertens.19(7), 1177–1183 (2001).
   PubMed Web of Science ®Google Scholar
• Cannon RO 3rd, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. J. Am. Coll. Cardiol.1(6), 1359–1373 (1983).
   PubMed Web of Science ®Google Scholar
• Panting JR, Gatehouse PD, Yang GZ et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N. Engl. J. Med.346(25), 1948–1953 (2002).
   PubMed Web of Science ®Google Scholar
• Bernhardt P, Levenson B, Albrecht A, Engels T, Strohm O. Detection of cardiac small vessel disease by adenosine-stress magnetic resonance. Int. J. Cardiol.121(3), 261–266 (2007).
   PubMed Web of Science ®Google Scholar
• Alfakih K, Walters K, Jones T, Ridgway J, Hall AS, Sivananthan M. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI. Hypertension44(2), 175–179 (2004).
   PubMed Web of Science ®Google Scholar
• Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension35(2), 580–586 (2000).
   PubMed Web of Science ®Google Scholar
• Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation81(3), 815–820 (1990).
   PubMed Web of Science ®Google Scholar